Tag: Clinical Trials
Preprint, Peer-Reviewed Pairs of Studies Generally Concordant
Sample sizes, primary end points, interpretations mainly concordant for studies published on medRxiv, then in journals
Study Explores Impact of FDA Approval of Aducanumab on Trial Participation
Individuals who were independently aware of the FDA decision demonstrated reduced willingness to participate
Second Death in Trial of Experimental Alzheimer Drug Raising Concerns
Doctors suspect that by stripping away amyloid deposits, lecanemab weakens blood vessels and leaves them vulnerable to bleeds
Most Pivotal Trials of New Drugs Recruit From Low-, Middle-Income Countries
Percentage of participants recruited from low-, middle-income countries was 8, 36, and 17 percent for cancer, cardiovascular, neurology trials
FDA Oversight of Clinical Trials Described as ‘Grossly Inadequate’
Article describes inadequate oversight relating to development of COVID-19 vaccines and predating the pandemic
Many U.S. Adults Unlikely to Enroll in Drug Trials for Dementia Prevention
Those with a family history or higher self-perceived risk are more likely to participate
NIH Investigating COVID-19 Experiments Conducted at Boston University
New Platform Matches Patients to Precision Oncology Trials
Clinical trial consents happened 55 days sooner for patients using MatchMiner compared with those using non-MatchMiner channels
People With Disabilities Often Excluded From Clinical Trials
Findings include exclusion of people with cognitive, visual, hearing, mobility, and other disabilities, without documented justification
More Adolescents and Young Adults Enrolled in Trials After Launch of NCTN
AYAs enrolled in trials increased from 9.5 to 14.0 percent after launch of National Clinical Trials Network
